Disclosure of confidential business information
This guidance document describes how we disclose confidential business information (CBI) under paragraph 21.1(3)(c) of the Food and Drugs Act.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-06-02
Data overview
- Formats
- HTML
- File languages
- English, French